Nasal High Flow Therapy for Bronchiolitis

Written By CCRG

Franklin D, Miller L, Pham TM, Frampton C, Moloney S, Waugh J, Fairless S, Hobbins S, Grew S, George S, Fahy R, Morel D, Schibler A. J Paediatr Child Health. DOI 10.1111/jpc.16557

Aim: Uptake of nasal high-flow therapy in infants with bronchiolitis has grown in the last decade with some evidence suggesting a reduction in escalation of care. The effect of the implementation of recent available evidence on clinical practice remains unclear.

Methods: In a prospective observational study over 6 months in six metropolitan hospitals in Australia, we investigated the clinical practice of high-flow in infants admitted with bronchiolitis and an oxygen requirement. To assess the choice by clinicians of the initial oxygen therapy (standard oxygen or high-flow) the disease severity was measured by physiological parameters obtained prior to oxygen therapy commencement. Additional secondary outcomes were hospital length of stay and transfers to intensive care.

CCRG
Previous

Acute Kidney Injury after Heart Transplantation: Risk Stratification is Good; Risk Modification is Better-But can we do it?
Next

Association between changes in disease severity and physical function after surviving a critical illness